Dexcom lifts 2026 revenue outlook after positive Q3
Dexcom has achieved Q3 revenues of around $1.3bn, coinciding with a series of operational milestones being met throughout the quarter,…
02 Nov 2026
Omron Healthcare begins production at first India plant
Omron Healthcare, the medical-device arm of Japan's Omron, has commenced full-scale blood pressure monitor production at its first Indian manufacturing facility, situated near Chennai in Tamil Nadu. The subsidiary running…
02 Nov 2026
J&J data show lower mortality with Impella in HRPCI than CHIP-BCIS3
Johnson & Johnson (J&J) has reported findings from three separate clinical analyses demonstrating reduced mortality among high-risk percutaneous coronary intervention (HRPCI) patients supported by Impella heart pumps compared with rates…
30 Oct 2026
Abbott’s paravalvular leak treatment secures FDA approval
Abbott’s Amplatzer Paraclose Occluder has secured US Food and Drug Administration (FDA) approval, making it the first transcatheter device approved in the US market that is specifically designed for paravalvular…
30 Oct 2026
Baxter’s shares fall as Q3 probability dips despite revenue growth
Baxter has reported Q3 revenues of almost $3bn, but as it raises its 2026 outlook for the second consecutive quarter amid the positive financial performance, the company’s stock price also…
30 Oct 2026
FDA expands approval of Instylla’s Embrace HES for arterial bleeds
The US Food and Drug Administration (FDA) has cleared an expanded indication for Instylla’s Embrace hydrogel embolic system (HES) to treat peripheral arterial bleeds in vessels measuring up to 6mm.…
30 Oct 2026
StimCardio secures $30m in Series A round for wearable AF therapy
StimCardio Medical has completed an oversubscribed $30m Series A funding round to advance its non-invasive wearable, Rhyvive, for atrial fibrillation (AF). The investment round was led by Metis Medtech, alongside…